A5028760491- Cardiac Valve Diseases and Treatments
- Infective Endocarditis Diagnosis and Management
- Aortic Disease and Treatment Approaches
- Peripheral Artery Disease Management
- Atrial Fibrillation Management and Outcomes
- Cardiac Imaging and Diagnostics
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiovascular Function and Risk Factors
University of North Dakota
2023-2024
Sanford Health
2018-2024
Abstract Introduction Transcatheter aortic valve replacement (TAVR) has overtaken surgical and revolutionized the treatment strategy for replacement. Little is known on disparities among minorities, especially American Indians (AI), undergoing this procedure. We explore TAVR outcomes to identify at our institution. Methods Retrospective chart review was completed patients who underwent a North Dakota community hospital between 2012 2021. There were 1133 non-AI 20 AI identified ( n = 1153)....
Chronic Obstructive Pulmonary Disease (COPD) is a common comorbidity in patients with aortic stenosis and when severe surgical valve replacement contraindication. However, the impact of COPD undergoing TAVR unclear. This study defines risks/benefits including quality life, morbidities, mortality patients. All from August 2012 to June 2023 at single institution were retrospectively reviewed (n = 1565). 1273 preoperative pulmonary function testing studied. FEV1/FVC FEV1% predicted used...
Despite advancements in valve implantation devices, vascular access complications (VAC) remain a significant cause of morbidity and mortality for those undergoing transcatheter aortic replacement (TAVR). We describe pre-operative imaging analysis the aortoiliac femoral arterial beds using TransAtlantic intersociety consensus (TASC) score, ilio-femoral tortuosity, procedural characteristics to identify anatomic risk factors predictive VAC TAVR.
This case describes an 84-year-old female with chronic diastolic heart failure, coronary artery disease status post bypass and percutaneous intervention, hypertension, diabetes mellitus kidney stage III, who presented progressive dyspnea found to have severe aortic stenosis demonstrated by echocardiogram (aortic valve area, .06 <sup>cm2</sup>; mean gradient, 42 mm Hg). She was evaluated the Heart Team deemed be a candidate for transfemoral transcatheter replacement (TAVR) after computed...